Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
***weekend promotion extended*** 2 more days site-wide discount of 20% use promocode 'weekend20' BPC-157 is a synthetic peptide composed of a defined amino acid sequence produced through controlled peptide synthesis
FDA Status BPC-157s FDA status remains not approved for medical use or over-the-counter sale. In April 2026, compounding restrictions were adjusted, but the peptide still cannot be prescribed or sold for human/animal consumption
Future studies should employ mitochondria-targeted ROS sensors (e.g., MitoSOX) to provide more definitive evidence
(2) The Human Evidence Gap No completed, peer-reviewed Phase II or Phase III randomized controlled trials in humans have been published as of July 2025
Fong FL, Shah NP, Kirjavainen P, El-Nezami H (2016) Mechanism of action of probiotic bacteria on intestinal and systemic immunities and antigen-presenting cells
